
Plants, Journal Year: 2024, Volume and Issue: 13(23), P. 3397 - 3397
Published: Dec. 3, 2024
and
Language: Английский
Plants, Journal Year: 2024, Volume and Issue: 13(23), P. 3397 - 3397
Published: Dec. 3, 2024
and
Language: Английский
ChemistrySelect, Journal Year: 2025, Volume and Issue: 10(13)
Published: April 1, 2025
Abstract Caralluma tuberculata , a medicinal plant of the Apocynaceae family, has long been used to treat inflammation, oxidative stress, and metabolic problems. This study aimed analyze phytochemical composition aerial parts C. evaluate its biological activities, which included antioxidant, anticancer, antibacterial, antidiabetic properties. The were analyzed using GC–MS. Total phenolic content (TPC) total flavonoid (TFC) determined by Folin Ciocalteu aluminum chloride methods, respectively. In vitro activities performed. silico molecular docking was utilized Maestro 11.5 from Schrödinger suite. TPC (83.12 ± 1.26 mg GAE/g extract) extract richer compared TFC (47.45 1.37 QE/g exhibited moderate antioxidant activity in DPPH (IC 50 : 127.99 1.72 µg/mL) ABTS 182.61 1.88 assays. It cytotoxic MCF‐7 with IC = 161.62 1.92 µg/mL HepG2 cells values 151.87 2.15 regulated apoptotic pathways, increasing pro‐apoptotic gene expression. Antibacterial studies revealed broad range action, particularly against Gram‐positive bacteria. tuberculate's had minimum bactericidal concentration (MIC) ranging 6.25 µg/mL. effectively inhibited α‐amylase α‐glucosidase, indicating potential effects, 317.12 2.17 372.14 1.64 µg/mL, Molecular that 2,3‐dihydro‐3,5‐dihydroxy‐6‐methyl‐4h‐pyran‐4‐one, 8,8‐Dimethyl‐4‐methylene‐1‐oxaspiro [2.5] oct‐5‐ene, 2,5‐Monomethyl molecules identified C . most active sites three receptors studied. conclusion, diverse profile promising properties, making it prospective option for developing therapies disorders, infections, cancer, age‐related illnesses.
Language: Английский
Citations
0Pharmaceuticals, Journal Year: 2025, Volume and Issue: 18(5), P. 648 - 648
Published: April 28, 2025
Background/Objectives: Ginseng has been a traditional remedy for centuries, known its diverse benefits such as anti-inflammation, antioxidant, bactericidal, fungicidal antidiabetic, and anticancer effects. This study employs network pharmacology approach with molecular dynamics simulation to investigate the potential mechanisms through which ginseng-derived compounds control hypertension. Methods: The total of 70 bioactive were identified from literature classified ginsenosides, fall under Protopanaxadiol-type Protopanaxatriol-type Ocotillol-type saponins. target proteins related hypertension collected drug bank, interactions between examined using STRING 12.0 Cytoscape 3.10.1. Bioinformatics tools used analyze biological enrichment genes. core targets extracted subjected docking studies. Similarly, score below −6.0 kcal/mol was further visualized by performing see binding affinity complexes. Finally, pharmacokinetics toxicity evaluated computational tools. Results: Molecular results revealed that Floralquinquenoside C, Ginsenoside Rg6, Notoginsenoside T1, B exhibited strong stability Angiotensin-converting enzyme (ACE) Carbonic Anhydrase-I (CA-I), alters renin–angiotensin system, calcium signaling pathway, adrenergic in cardiomyocytes, c-GMP-PKG etc., regulate high blood pressure. Conclusions: show phytochemicals ginseng could act candidates management hypertension, may help minimize side effects caused synthetic anti-hypertensive drugs available on market.
Language: Английский
Citations
0Pharmacophore, Journal Year: 2024, Volume and Issue: 15(4), P. 46 - 53
Published: Jan. 1, 2024
Language: Английский
Citations
0Plants, Journal Year: 2024, Volume and Issue: 13(23), P. 3397 - 3397
Published: Dec. 3, 2024
and
Language: Английский
Citations
0